UM Sylvester Comprehensive Cancer Center at Kendall — Miami, Florida

UM Sylvester Comprehensive Cancer Center at Kendall is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

UM Sylvester Comprehensive Cancer Center at Kendall has participated in 94 clinical trials with 82 currently active.

Therapeutic areas: Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UM Sylvester Comprehensive Cancer Center at Kendall?

UM Sylvester Comprehensive Cancer Center at Kendall has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UM Sylvester Comprehensive Cancer Center at Kendall conducted?

UM Sylvester Comprehensive Cancer Center at Kendall has 94 clinical trials on record, with 82 currently active. Their work covers Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant.

Is UM Sylvester Comprehensive Cancer Center at Kendall accredited by Crixeo Health?

UM Sylvester Comprehensive Cancer Center at Kendall has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UM Sylvester Comprehensive Cancer Center at Kendall?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.